MSD is also bracing for a $200m hit due to tariffs as it accelerates US manufacturing and shifts its global supply strategy.

Merck said the expected tariff charge primarily reflects levies between the U.S. and China, but does not account for Trump’s planned pharmaceutical tariffs.

In its first-quarter results update, MSD – which is known as Merck & Co in the US and Canada – said it expects full-year ...

We recently published a list of the 11 Cheap NYSE Stocks to Invest in According to Hedge Funds. In this article, we are going ...

Merck is growing pharma sales and expanding margins, led by strong KEYTRUDA performance and cost discipline. Read more about ...

We recently published a list of 10 Best Pharma Stocks to Buy for Long Term Growth. In this article, we are going to take a ...

Fiverr International's prospects look bright, thanks to the fast ... thanks to the human papillomavirus (HPV) products Gardasil and Gardasil 9. It's also a leader in the animal health business.

AIIMS Delhi has developed a blood test using ddPCR tech to detect HPV DNA for early cervical cancer detection, relapse ...

We recently published a list of the 11 Most Undervalued Quality Stocks to Buy Now. In this article, we are going to take a ...

With regard to the HPV vaccine, Gardasil, ex-U.S. sales are expected ... Merck’s stock is also cheaper than most other large drugmakers like AbbVie, AstraZeneca, Novo Nordisk and Eli Lilly ...

Merck faces headwinds like declining sales of the HPV vaccine, Gardasil, and diabetes drug ... % in the past year compared with a decline of 3.9% for the industry. Merck MRK stock has declined ...

Shares fell more than 10% as Merck paused Gardasil shipments ... vaccine makers like GSK (we model 14% of GSK revenue from US vaccine sales in 2024), Pfizer (12%), Merck (9%), and Sanofi (6%).